Beyond genetics: scaling patient education for any complex decision
Genetics is the hardest patient conversation in medicine, which makes it the proving ground, not the ceiling. The same model educates patients on medications, procedures, and trials.
By The Igentify Team
Igentify started in genetics for a reason: it's one of the hardest patient conversations in medicine. Results are dense, the stakes are personal, and the science is easy to misunderstand. If a digital experience can guide someone through a hereditary-cancer result with clarity and empathy, the same model applies almost anywhere education and consent are the bottleneck.
Genetics is the credential, not the limit
The depth genetics demands, personalized explanation, comprehension you can measure, multilingual access, and digital consent, is exactly what's missing in medication education, procedure consenting, and clinical-trial enrollment. The hard environment proves the approach.
The same engine, new indications
Personalized video education, a 24/7 digital advisor, and digital consent are indication-agnostic. The content changes; the model does not: educate clearly, answer questions, capture consent, and escalate to a human when needed.
Why it matters
Every specialty faces the same scale problem: more patients who need to understand a complex decision than there are clinicians to explain it one by one. Proving the model in genetics means it's ready for the next conversation, whatever it is.
Start with the hardest problem, and the rest gets easier.
on your own workflows.